Literature DB >> 29496907

Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS).

Raghuveera Kumar Goel1, Marta Paczkowska2, Jüri Reimand2,3, Scott Napper1,4, Kiven Erique Lukong5.   

Abstract

SRMS (Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites), also known as PTK 70 (Protein tyrosine kinase 70), is a non-receptor tyrosine kinase that belongs to the BRK family of kinases (BFKs). To date less is known about the cellular role of SRMS primarily because of the unidentified substrates or signaling intermediates regulated by the kinase. In this study, we used phosphotyrosine antibody-based immunoaffinity purification in large-scale label-free quantitative phosphoproteomics to identify novel candidate substrates of SRMS. Our analyses led to the identification of 1258 tyrosine-phosphorylated peptides which mapped to 663 phosphoproteins, exclusively from SRMS-expressing cells. DOK1, a previously characterized SRMS substrate, was also identified in our analyses. Functional enrichment analyses revealed that the candidate SRMS substrates were enriched in various biological processes including protein ubiquitination, mitotic cell cycle, energy metabolism and RNA processing, as well as Wnt and TNF signaling. Analyses of the sequence surrounding the phospho-sites in these proteins revealed novel candidate SRMS consensus substrate motifs. We utilized customized high-throughput peptide arrays to validate a subset of the candidate SRMS substrates identified in our MS-based analyses. Finally, we independently validated Vimentin and Sam68, as bona fide SRMS substrates through in vitro and in vivo assays. Overall, our study identified a number of novel and biologically relevant SRMS candidate substrates, which suggests the involvement of the kinase in a vast array of unexplored cellular functions.
© 2018 Goel et al.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29496907      PMCID: PMC5930402          DOI: 10.1074/mcp.RA118.000643

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  89 in total

Review 1.  Reaching for the stars: Linking RNA binding proteins to diseases.

Authors:  Stéphane Richard
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  Multidimensional proteomics for cell biology.

Authors:  Mark Larance; Angus I Lamond
Journal:  Nat Rev Mol Cell Biol       Date:  2015-04-10       Impact factor: 94.444

3.  Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.

Authors:  Gaofeng Fan; Saadat Aleem; Ming Yang; W Todd Miller; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

4.  Studies of phosphoproteomic changes induced by nucleophosmin-anaplastic lymphoma kinase (ALK) highlight deregulation of tumor necrosis factor (TNF)/Fas/TNF-related apoptosis-induced ligand signaling pathway in ALK-positive anaplastic large cell lymphoma.

Authors:  Fang Wu; Peng Wang; Jingdong Zhang; Leah C Young; Raymond Lai; Liang Li
Journal:  Mol Cell Proteomics       Date:  2010-04-14       Impact factor: 5.911

5.  Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats.

Authors:  Mirja Nurmio; Henna Joki; Jenny Kallio; Jorma A Määttä; H Kalervo Väänänen; Jorma Toppari; Kirsi Jahnukainen; Tiina Laitala-Leinonen
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-04       Impact factor: 4.219

6.  Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.

Authors:  Lei Dong; Wen-Mei Yu; Hong Zheng; Mignon L Loh; Silvia T Bunting; Melinda Pauly; Gang Huang; Muxiang Zhou; Hal E Broxmeyer; David T Scadden; Cheng-Kui Qu
Journal:  Nature       Date:  2016-10-26       Impact factor: 49.962

7.  Differential expression of novel tyrosine kinase substrates during breast cancer development.

Authors:  Yunhao Chen; Lee-Yee Choong; Qingsong Lin; Robin Philp; Chee-Hong Wong; Boon-Keong Ang; Yee-Ling Tan; Marie-Chiew-Shia Loh; Choy-Leong Hew; Nilesh Shah; Brian J Druker; Poh-Kuan Chong; Yoon-Pin Lim
Journal:  Mol Cell Proteomics       Date:  2007-09-12       Impact factor: 5.911

8.  Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68.

Authors:  Mikael Feracci; Jaelle N Foot; Sushma N Grellscheid; Marina Danilenko; Ralf Stehle; Oksana Gonchar; Hyun-Seo Kang; Caroline Dalgliesh; N Helge Meyer; Yilei Liu; Albert Lahat; Michael Sattler; Ian C Eperon; David J Elliott; Cyril Dominguez
Journal:  Nat Commun       Date:  2016-01-13       Impact factor: 14.919

9.  Global analysis of human nonreceptor tyrosine kinase specificity using high-density peptide microarrays.

Authors:  Yang Deng; Nilda L Alicea-Velázquez; Ludovic Bannwarth; Soili I Lehtonen; Titus J Boggon; Heung-Chin Cheng; Vesa P Hytönen; Benjamin E Turk
Journal:  J Proteome Res       Date:  2014-08-28       Impact factor: 4.466

10.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

View more
  8 in total

1.  Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.

Authors:  Juncheng Dai; Zhihua Li; Christopher I Amos; Rayjean J Hung; Adonina Tardon; Angeline S Andrew; Chu Chen; David C Christiani; Demetrios Albanes; Erik H F M van der Heijden; Eric J Duell; Gad Rennert; James D Mckay; Jian-Min Yuan; John K Field; Jonas Manjer; Kjell Grankvist; Loic Le Marchand; M Dawn Teare; Matthew B Schabath; Melinda C Aldrich; Ming-Sound Tsao; Philip Lazarus; Stephen Lam; Stig E Bojesen; Susanne Arnold; Xifeng Wu; Aage Haugen; Vladimir Janout; Mikael Johansson; Yonathan Brhane; Ana Fernandez-Somoano; Lambertus A Kiemeney; Michael P A Davies; Shanbeh Zienolddiny; Zhibin Hu; Hongbing Shen
Journal:  Carcinogenesis       Date:  2019-05-14       Impact factor: 4.944

2.  CT-detected extramural venous invasion-related gene signature for the overall survival prediction in patients with gastric cancer.

Authors:  Bo Gao; Caizhen Feng; Fan Chai; Shengcai Wei; Nan Hong; Yingjiang Ye; Yi Wang; Jin Cheng
Journal:  Cancer Med       Date:  2021-09-12       Impact factor: 4.452

3.  The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.

Authors:  Jung Mi Park; Seung Wook Yang; Wei Zhuang; Asim K Bera; Yan Liu; Deepak Gurbani; Sergei J von Hoyningen-Huene; Sadie Miki Sakurada; Haiyun Gan; Shondra M Pruett-Miller; Kenneth D Westover; Malia B Potts
Journal:  PLoS Biol       Date:  2021-06-02       Impact factor: 8.029

Review 4.  Structure, Function, and Regulation of the SRMS Tyrosine Kinase.

Authors:  Chakia J McClendon; W Todd Miller
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

5.  Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates.

Authors:  Raghuveera Kumar Goel; Mona Meyer; Marta Paczkowska; Jüri Reimand; Frederick Vizeacoumar; Franco Vizeacoumar; TuKiet T Lam; Kiven Erique Lukong
Journal:  Proteome Sci       Date:  2018-08-18       Impact factor: 2.480

6.  Candidate Genes Associated with Delayed Neuropsychomotor Development and Seizures in a Patient with Ring Chromosome 20.

Authors:  Thiago Corrêa; Amanda Cristina Venâncio; Marcial Francis Galera; Mariluce Riegel
Journal:  Case Rep Genet       Date:  2020-01-21

7.  Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants.

Authors:  Maan T Khayat; Abdelsattar M Omar; Farid Ahmed; Mohammad I Khan; Sara M Ibrahim; Yosra A Muhammad; Azizah M Malebari; Thikryat Neamatallah; Moustafa E El-Araby
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

8.  A Progressive Loss of phosphoSer138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington's Disease: Possible Sex-Dependent Signaling.

Authors:  Akanksha Baharani; Zelan Wei; William J Roesler; Darrell D Mousseau
Journal:  Cell Mol Neurobiol       Date:  2020-10-27       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.